UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 278

Sortiert nach

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5410-5417

2009

Volltextzugriff (PDF)

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (21), p.8573-8578

2009

Volltextzugriff (PDF)

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Clinical cancer research, 2012-04, Vol.18 (7), p.2099-2107

2012

Volltextzugriff (PDF)

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

Clinical cancer research, 2008-07, Vol.14 (13), p.4200-4205

2008

Volltextzugriff (PDF)

Bullying Perpetration and Victimization in Youth: Associations with Irritability and Anxiety

Child psychiatry and human development, 2022-10, Vol.53 (5), p.1075-1082

2022

Volltextzugriff (PDF)

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

Clinical cancer research, 2007-09, Vol.13 (17), p.5183-5194

2007

Volltextzugriff (PDF)

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

Expert review of anticancer therapy, 2010-07, Vol.10 (7), p.997-1008

2010

Volltextzugriff (PDF)

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.569-580

2011

Volltextzugriff (PDF)

Delayed treatment and continued growth of nonmelanoma skin cancer

Journal of the American Academy of Dermatology, 2011-05, Vol.64 (5), p.839-848

2011

Volltextzugriff (PDF)

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

British journal of clinical pharmacology, 2011-08, Vol.72 (2), p.294-305

2011

Volltextzugriff (PDF)

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

Molecular biotechnology, 2010-02, Vol.44 (2), p.152-167

2010

Volltextzugriff (PDF)

Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies

Clinical cancer research, 2007-09, Vol.13 (18), p.5411-5417

2007

Volltextzugriff (PDF)

Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008-02, Vol.862 (1), p.213-218

2008

Volltextzugriff (PDF)

Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues

Molecular cancer therapeutics, 2015-10, Vol.14 (10), p.2228-2237

2015

Volltextzugriff (PDF)

Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

European journal of cancer (1990), 2010-01, Vol.46 (2), p.340-347

2010

Volltextzugriff (PDF)

Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids

ChemMedChem, 2016-12, Vol.11 (23), p.2621-2629

2016

Volltextzugriff (PDF)

Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

Clinical cancer research, 2009-02, Vol.15 (4), p.1496-1503

2009

Volltextzugriff (PDF)

Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma

Journal of pharmaceutical and biomedical analysis, 2008-01, Vol.46 (2), p.362-367

2008

Volltextzugriff (PDF)

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

British journal of haematology, 2010-01, Vol.148 (2), p.256-267

2010

Volltextzugriff (PDF)

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors

Oncotarget, 2014-09, Vol.5 (18), p.8161-8172

2014

Volltextzugriff (PDF)

Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models

Cancer biology & therapy, 2010-07, Vol.10 (1), p.38-43

2010

Volltextzugriff (PDF)

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

Clinical pharmacology and therapeutics, 2006-08, Vol.80 (2), p.192-201

2006

Volltextzugriff (PDF)

Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin Reaction

Pharmacotherapy, 2010-01, Vol.30 (1), p.52-56

2010

Volltextzugriff (PDF)

Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice

Journal of experimental & clinical cancer research, 2009-07, Vol.28 (1), p.99-99, Article 99

2009

Volltextzugriff (PDF)

Families, Mental Health, and Delinquency: Testing Sexual Crime Typologies of Youth Who Sexually Harm

Youth violence and juvenile justice, 2022-07, Vol.20 (3), p.250-275

2022

Volltextzugriff (PDF)

1 – 25 von 278

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(254)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(278)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(156)
Humans
(106)
Female
(73)
Male
(72)
Biological And Medical Sciences
(61)
Medical Sciences
(51)
Animals
(38)
Adult
(32)
Middle Aged
(32)
Oncology
(32)
Pharmacology. Drug Treatments
(24)
Aged
(23)
Pharmacology & Pharmacy
(21)
Social Sciences
(20)
Mice
(19)
Physical Sciences
(18)
Analysis
(17)
Fundamental And Applied Biological Sciences. Psychology
(17)
Treatment Outcome
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

Bullying Perpetration and Victimization in Youth: Associations with Irritability and Anxiety

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

Delayed treatment and continued growth of nonmelanoma skin cancer

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies

Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment

Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues

Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids

Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors

Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin Reaction

Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice

Families, Mental Health, and Delinquency: Testing Sexual Crime Typologies of Youth Who Sexually Harm

Suchergebnisse filtern